美国Berg Diagnostics 
Berg Diagnostics LLC 简介
Berg Diagnostics 是一家总部位于波士顿的分子诊断公司，致力于提供高通量组学分子表达谱、生物标志物确认和规范化生物分析，从而加快分子治疗与诊断的发展。该公司凭借其一流的仪器操作平台来促进治疗与生物标志物开发项目的完成。
Berg Biosystems LLC 简介
Berg Biosystems 是一家总部位于马萨诸塞州波士顿的公司，利用创新方法进行系统生物学研究，并利用系统工程和生物信息学模块进行交叉验证生物学输出。Berg Interrogative Biology® 药物发现平台能够快速精确地识别用于药物发现和开发的疗法和生物标志物。该公司利用网络生物模板来进行疾病的病理生理学研究。


Berg Diagnostics is a molecular diagnostics company focused on the discovery, validation, and commercialization of novel diagnostic tests.
Personalized medicine has the potential to revolutionize patient care. Molecular Diagnostics (MDx) holds great promise as tools that allow physicians to differentiate patient-specific characteristics, design personalized treatment approaches, and ultimately improve patient outcomes. The successful delivery of molecular diagnostics is the foundation of personalized medicine. Berg Diagnostics is well positioned to translate the promise of personalized medicine into practice.
We have developed and are continuously developing enabling technologies such as molecular profiling, biomarker validation, and regulated bioanalysis to facilitate our partners to decipher differential molecular signatures between normal and disease states, reveal underlying pathophysiology, identify and validate novel biomarkers.
Our end-points are novel diagnostic tests. As personalized medicine is redefining the landscape of health industry and disrupting existing business models, we believe cross-industry collaboration is a key to success. Working with our partners, we have developed and marketed over 100 human ELISA kits.
At Berg Diagnostics, we are committed to the health and wellness of our patients. We strive to be a leader not only in molecular diagnostics, but also in solving the healthcare challenges that face our society.
We are dedicated to the success of innovative ideas as well as the partners that we work with for transformative change. This is our commitment. We resolve to engage the best entities as partners in working together toward this vision.